Literature DB >> 12734269

Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2.

Reiko Saito1, Takatsugu Sakai, Isamu Sato, Yasuko Sano, Hitoshi Oshitani, Mizuho Sato, Hiroshi Suzuki.   

Abstract

In two influenza seasons during which H1N1 and H3N2 cocirculated, resistance was more frequent in H3N2 strains than in H1N1 strains after amantadine treatment. Predominant amino acid substitutions in M2 protein occurred at position 31 (serine to asparagine) in H3N2 strains and at position 27 (valine to alanine) in H1N1 strains.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12734269      PMCID： PMC154689          DOI： 10.1128/JCM.41.5.2164-2165.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan.

Authors:  H Masuda; H Suzuki; H Oshitani; R Saito; S Kawasaki; M Nishikawa; H Satoh
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

2.  Excess amantadine use and resistant viruses.

Authors:  H Suzuki; R Saito; H Oshitani
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

3.  The effectiveness of influenza vaccine against influenza a (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons.

Authors:  Reiko Saito; Hiroshi Suzuki; Hitoshi Oshitani; Takatsugu Sakai; Nao Seki; Naohito Tanabe
Journal:  Infect Control Hosp Epidemiol       Date:  2002-02       Impact factor: 3.254

4.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Carolyn B Bridges; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; James A Singleton
Journal:  MMWR Recomm Rep       Date:  2002-04-12

5.  Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

Authors:  E E Mast; M W Harmon; S Gravenstein; S P Wu; N H Arden; R Circo; G Tyszka; A P Kendal; J P Davis
Journal:  Am J Epidemiol       Date:  1991-11-01       Impact factor: 4.897

6.  Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.

Authors:  R B Belshe; B Burk; F Newman; R L Cerruti; I S Sim
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

7.  Influenza A virus M2 ion channel protein: a structure-function analysis.

Authors:  L J Holsinger; D Nichani; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Children with influenza A infection: treatment with rimantadine.

Authors:  C B Hall; R Dolin; C L Gala; D M Markovitz; Y Q Zhang; P H Madore; F A Disney; W B Talpey; J L Green; A B Francis
Journal:  Pediatrics       Date:  1987-08       Impact factor: 7.124

9.  Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.

Authors:  F G Hayden; R B Belshe; R D Clover; A J Hay; M G Oakes; W Soo
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245

10.  Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.

Authors:  P Houck; M Hemphill; S LaCroix; D Hirsh; N Cox
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  24 in total

1.  Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.

Authors:  Yacine Abed; Nathalie Goyette; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 2.  The threat of avian influenza A (H5N1). Part III: Antiviral therapy.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-04-12       Impact factor: 3.402

3.  In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Authors:  Katrina Sleeman; Vasiliy P Mishin; Varough M Deyde; Yousuke Furuta; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

4.  Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.

Authors:  Mozibur Rahman; Sheikh Ariful Hoque; Mohammad Ariful Islam; Sabita Rezwana Rahman
Journal:  Virus Genes       Date:  2017-04-11       Impact factor: 2.332

Review 5.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

6.  Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

Authors:  Jun Wang; Chunlong Ma; Giacomo Fiorin; Vincenzo Carnevale; Tuo Wang; Fanghao Hu; Robert A Lamb; Lawrence H Pinto; Mei Hong; Michael L Klein; William F DeGrado
Journal:  J Am Chem Soc       Date:  2011-07-21       Impact factor: 15.419

7.  Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.

Authors:  Jun Wang; Chunlong Ma; Victoria Balannik; Lawrence H Pinto; Robert A Lamb; William F Degrado
Journal:  ACS Med Chem Lett       Date:  2011-04-14       Impact factor: 4.345

8.  Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

Authors:  Victoria Balannik; Jun Wang; Yuki Ohigashi; Xianghong Jing; Emma Magavern; Robert A Lamb; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

9.  Detection of adamantane-resistant influenza on a microarray.

Authors:  Michael B Townsend; James A Smagala; Erica D Dawson; Varough Deyde; Larisa Gubareva; Alexander I Klimov; Robert D Kuchta; Kathy L Rowlen
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

10.  Solid-supported membrane technology for the investigation of the influenza A virus M2 channel activity.

Authors:  Victoria Balannik; Petr Obrdlik; Samsoon Inayat; Catrin Steensen; Jun Wang; Joshua M Rausch; William F DeGrado; Bela Kelety; Lawrence H Pinto
Journal:  Pflugers Arch       Date:  2009-11-28       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.